Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

...

6 Sep 2013

Short-term blood sugar control in diabetes patients has limited effect on risk of cardiovascular problems

An international study has shown that short-term blood sugar control in patients with diabetes has a limited effect on their risk of cardiovascular problems, such as heart disease and stroke.

6 Sep 2013

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

...

5 Sep 2013

Biomarker strategy in suspected ACS patients has potential to change clinical practice

An emergency department strategy that uses two biomarkers to triage patients with suspected acute coronary syndrome (ACS) can increase the rate of early, safe hospital discharge, according to results of the Biomarkers in Cardiology 8 (BIC-8) trial.

5 Sep 2013

Experimental agent fails to increase HDL levels, reveals new study

The search continues for an agent that increases high-density lipoprotein (HDL) and reduces arterial plaque, after the experimental apolipoprotein A1 (apoA1) inducer, RVX-208 failed to do so in the ApoA1 Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation (ASSURE) study.

5 Sep 2013

Preventive PCI for patients with ST elevation myocardial infarction results in better outcomes

Heart attack patients with ST elevation who undergo a preventive procedure to unblock additional coronary arteries have significantly better outcomes than those whose treatment is confined to the culprit blockage only, according to the results of the Preventive Angioplasty in Myocardial Infarction (PRAMI) Trial

5 Sep 2013

Anti-thrombotic therapy interruption has no influence on perioperative complications in cardiac patients

A shortened pre-surgical interruption of anti-thrombotic therapy, compared to the more traditional one-week interruption, has no influence on perioperative complications in cardiac patients, according to the results of the PRAGUE 14 trial.

5 Sep 2013

TASTE trial questions the usefulness of thrombus aspiration after heart attack

Aspiration of the blood clot or "thrombus" that causes a heart attack before re-opening a patient's artery with a balloon catheter does not improve survival compared to performing balloon dilation and stenting alone according to the results of the Thrombus Aspiration in ST- Elevation myocardial infarction in Scandinavia (TASTE) trial.

5 Sep 2013

Hokusai-VTE findings provide fresh insight into patients with pulmonary embolism

In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin (LMWH), according to the results of the Hokusai-VTE trial.

5 Sep 2013

Multiple risk factors eliminate impact of AF on stroke risk, but more research is needed

Dr Benn Christiansen said: "We know that atrial fibrillation increases the risk of ischemic stroke. And in patients with atrial fibrillation or previous ischemic stroke, the risk of stroke increases with the number of risk factors.

5 Sep 2013

World's leading scientists to explore health benefits of Hydrogen Sulfide at conference

A gas associated with the smell of rotten of eggs is now being proven to have widespread health benefits. Hydrogen Sulfide is widely known as a poisonous and corrosive substance, but now a mounting body of evidence suggests it could be used in a wide range of treatments for some of the biggest health problems of our time. A conference hosted by the University of Exeter will bring together world-leading scientists to explore the emerging possibilities.

5 Sep 2013

Study reveals large gap between detection, control of hypertension across all countries

In a study that included more than 140,000 participants from17 countries of varying income levels, researchers found a large gap between both detection and control of hypertension across all countries studied, with just over half of participants with hypertension aware of their diagnosis, and about one-third of those being treated for hypertension successfully controlling their blood pressure, according to a study in the September 4 issue of JAMA.

5 Sep 2013

Study: People with cataract-related vision loss who undergo cataract surgery live longer

People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.

5 Sep 2013

Secondary prevention drugs produce decline in stroke risk after AMI in diabetic patients

The findings were presented at the ESC Congress today by Ms Stina Jakobsson from Sweden. They reveal that reperfusion therapy and secondary prevention drugs produced the decline and brought stroke risk after AMI closer to that of non-diabetics.

5 Sep 2013

Scientists develop new form of aspirin to cope with resistance

Scientists are reporting development of a new form of aspirin - taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke - that could extend aspirin's benefits to people who may not respond to the drug. Their advance toward coping with "aspirin resistance" appears in the journal ACS Nano.

5 Sep 2013

Seniors make bigger gains against heart disease than younger people

Media outlets report that rates for so-called avoidable deaths from cardiovascular disease declined among people under age 75, but the rates of decline were substantially slower among adults under age 65 and among blacks, according to an analysis by the Centers for Disease Control and Prevention.

5 Sep 2013

Underweight women with CAD should gain weight to reduce risk of death

Being underweight increases the death risk of women with coronary artery disease (CAD) by 2-fold, according to research presented at the ESC Congress today by Dr Aziza Azimi from Denmark. The study suggests that underweight women with CAD should gain weight to reduce their risk of death.

5 Sep 2013

People with CVD more likely to take preventive medicines when combined in one pill

People are much more likely to take preventive medicines if they're combined in one pill, an international study has found. The findings are published today in the Journal of the American Medical Association.

5 Sep 2013

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi US and POZEN Inc. announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor, and enteric-coated aspirin in a single tablet ("PA"), PA8140 and PA32540.

5 Sep 2013

First Edition: September 4, 2013

Todays headlines include reports about how the Balitmore Ravens will be part of the effort to raise public awareness about Maryland's health exchange.

4 Sep 2013

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Short-term blood sugar control in diabetes patients has limited effect on risk of cardiovascular problems

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Biomarker strategy in suspected ACS patients has potential to change clinical practice

Experimental agent fails to increase HDL levels, reveals new study

Preventive PCI for patients with ST elevation myocardial infarction results in better outcomes

Anti-thrombotic therapy interruption has no influence on perioperative complications in cardiac patients

TASTE trial questions the usefulness of thrombus aspiration after heart attack

Hokusai-VTE findings provide fresh insight into patients with pulmonary embolism

Multiple risk factors eliminate impact of AF on stroke risk, but more research is needed

World's leading scientists to explore health benefits of Hydrogen Sulfide at conference

Study reveals large gap between detection, control of hypertension across all countries

Study: People with cataract-related vision loss who undergo cataract surgery live longer

Secondary prevention drugs produce decline in stroke risk after AMI in diabetic patients

Scientists develop new form of aspirin to cope with resistance

Seniors make bigger gains against heart disease than younger people

Underweight women with CAD should gain weight to reduce risk of death

People with CVD more likely to take preventive medicines when combined in one pill

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

First Edition: September 4, 2013

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in